These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1221713)

  • 1. [Improvement of methods of control of the harmlessness of whooping-cough and DPT vaccines].
    Chuprinina RP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):126-7. PubMed ID: 1221713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic testing of associated whooping cough-diphtheria-tetanus vaccine with smaller doses of individual components].
    Polikar A; Solomonova K; Mikhailova V; Atanasova P; Khadzhikoleva Kh
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Aug; 50(8):88-92. PubMed ID: 4784594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Criteria for the assessment of the reactogenicity of ADPT vaccine].
    Zakharova MS; Novikova OM; Selidovkin DS; Kokina VIa; Lebedeva VI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jun; 50(6):44-9. PubMed ID: 4780911
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience of the People's Republic of Bulgaria in controlling diphtheria, tetanus and whooping cough].
    Polikar ACh; Solomonova KM; Mikhaĭlova VP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):92-6. PubMed ID: 3874506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory testing of combined diphtheria-tetanus-pertussis-typhoid vaccines.
    Csizér Z; Joó I; Réthy L; Juhász VP
    Prog Immunobiol Stand; 1971; 5():394-8. PubMed ID: 4660543
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Triple vaccine.
    Indian Pediatr; 1974 Nov; 11(11):763-4. PubMed ID: 4443052
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z; Zsidai J
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 11. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicorrelation analyses of toxic and antigenic components of DPT and DP vaccines produced in Japan.
    Ishida S; Kurokawa M; Asakawa S; Iwasa S; Sato Y; Arai H; Kondo S
    Jpn J Med Sci Biol; 1979 Oct; 32(5):295-304. PubMed ID: 544867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A collaborative investigation of a potency assay for adsorbed tetanus vaccines based on the protection of mice from tetanic paralysis.
    Mussett MV; Sheffield F
    J Biol Stand; 1976 Apr; 4(2):141-8. PubMed ID: 932045
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of the vaccines used in the prevention of bacterial diseases in children in Argentina during 1980-1986.
    Dellepiane NI; Spizzamiglio G
    Ann Sclavo Collana Monogr; 1986; 3(1-2):353-8. PubMed ID: 3501299
    [No Abstract]   [Full Text] [Related]  

  • 17. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS; Malivanova OM; Sokolovskaya AD; Shavrova EN; Kapustik LA
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):439-48. PubMed ID: 7320507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial vaccines and toxoids: review of safety and efficacy.
    Stollerman GH
    Adv Intern Med; 1978; 23():405-34. PubMed ID: 24328
    [No Abstract]   [Full Text] [Related]  

  • 20. The stability of bacterial vaccines at elevated temperatures.
    Stainer DW; Hart FE
    Dev Biol Stand; 1978; 41():249-53. PubMed ID: 753653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.